Cadrenal Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.06

-0.12 (-3.77%)

As of Jun 23, 10:14 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +453.9% upside

Low Target $12.65

Average Target $16.95

High Target $22.59

Current Price $3.06

Current
$3.06

Target
$16.95

$12.65 $16.95 avg $22.59

Scenario Analysis

Bear Case

$12.65

313.4%

Low target

Base Case

$16.95

+453.9%

Avg target

Bull Case

$22.59

+638.2%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$14.64

-79.1% from high

52-Week Low

$3.02

+1.3% from low

Target vs 52W High

$16.95

+15.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+20.2%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+25.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+33.2%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+37.1%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+214.2%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+173.1%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-34.5%